A patient taking lovastatin (Mevacor) for treatment of hypercholesterolemia should have follow-up because of the potential for: 1. nephrotoxicity. 2. cardiotoxicity. 3. hepatotoxic... A patient taking lovastatin (Mevacor) for treatment of hypercholesterolemia should have follow-up because of the potential for: 1. nephrotoxicity. 2. cardiotoxicity. 3. hepatotoxicity. 4. ototoxicity.
Understand the Problem
The question is asking which potential adverse effects require follow-up for a patient taking lovastatin for hypercholesterolemia. We need to assess the listed toxicity types and determine their relevance to the medication.
Answer
Hepatotoxicity
The final answer is hepatotoxicity.
Answer for screen readers
The final answer is hepatotoxicity.
More Information
Lovastatin, like other statins, can potentially cause liver damage, which is why liver function should be monitored.
Tips
A common mistake is assuming statins primarily affect organs like the heart or kidneys, but they mainly impact the liver.
Sources
AI-generated content may contain errors. Please verify critical information
Thank you for voting!
